Viking Therapeutics Inc (VKTX)
73.75
-4.26
(-5.46%)
USD |
NASDAQ |
May 16, 12:08
Viking Therapeutics Free Cash Flow: -54.87M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -54.87M |
December 31, 2023 | -73.38M |
September 30, 2023 | -66.66M |
June 30, 2023 | -60.50M |
March 31, 2023 | -62.51M |
December 31, 2022 | -48.40M |
September 30, 2022 | -49.82M |
June 30, 2022 | -47.25M |
March 31, 2022 | -47.24M |
December 31, 2021 | -47.59M |
September 30, 2021 | -40.72M |
June 30, 2021 | -35.12M |
March 31, 2021 | -28.35M |
December 31, 2020 | -21.78M |
September 30, 2020 | -28.03M |
June 30, 2020 | -26.11M |
March 31, 2020 | -25.90M |
December 31, 2019 | -24.75M |
September 30, 2019 | -15.69M |
June 30, 2019 | -17.79M |
Date | Value |
---|---|
March 31, 2019 | -16.60M |
December 31, 2018 | -18.76M |
September 30, 2018 | -20.02M |
June 30, 2018 | -17.85M |
March 31, 2018 | -16.78M |
December 31, 2017 | -14.76M |
September 30, 2017 | -13.28M |
June 30, 2017 | -12.60M |
March 31, 2017 | -11.63M |
December 31, 2016 | -11.07M |
September 30, 2016 | -11.91M |
June 30, 2016 | -12.65M |
March 31, 2016 | -11.05M |
December 31, 2015 | -8.732M |
September 30, 2015 | -5.873M |
June 30, 2015 | -3.082M |
March 31, 2015 | -1.902M |
December 31, 2014 | -1.591M |
September 30, 2014 | -1.160M |
June 30, 2014 | -0.5506M |
Free Cash Flow Range, Past 5 Years
-73.38M
Minimum
Dec 2023
-15.69M
Maximum
Sep 2019
-41.12M
Average
-43.98M
Median
Free Cash Flow Benchmarks
Eli Lilly and Co | -3.896B |
Pfizer Inc | 5.106B |
Madrigal Pharmaceuticals Inc | -391.12M |
Terns Pharmaceuticals Inc | -75.89M |
Amgen Inc | 7.098B |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -6.134M |
Cash from Investing (Quarterly) | -459.79M |
Cash from Financing (Quarterly) | 606.04M |
Free Cash Flow Per Share (Quarterly) | -0.0593 |
Free Cash Flow Yield | -0.74% |